Differences in pharmacokinetics and anti-inflammatory effects between decoction and maceration of Sanhuang Xiexin Tang in rats and mice

Planta Medica

Volumn 79, Issue 17, 2013, Pages 1666-1673

  Zhang, Qian ^a,b   Ma, Yue Ming ^a   Wang, Zheng Tao ^a,b   Wang, Chang Hong ^a,b  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Shanghai R and D Center for Standardization of Chinese Medicines   (China)

Author keywords

anti inflammatory; Coptis chinensis Franch; decoction; Labiatae; maceration; pharmacokinetics; Polygonaceae; Ranunculaceae; Rheum officinale Baill; Sanhuang Xiexin Tang; Scutellaria baicalensis Georgi

Indexed keywords

ALKALOID DERIVATIVE; ALOE EMODIN; ANTHRAQUINONE DERIVATIVE; BAICALIN; BERBERINE; CHINESE DRUG; COPTISINE; EMODIN; FLAVONE DERIVATIVE; INTERLEUKIN 10; JATRORRHIZINE; LIPOPOLYSACCHARIDE; PALMATINE; PROTOBERBERINE; RHEIN; SANHUANG XIEXIN TANG; SCUTELLARIAE RADIX; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; COPTIS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG HALF LIFE; ENZYME LINKED IMMUNOSORBENT ASSAY; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; RAT; RHIZOME; TANDEM MASS SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ALOE; COPTIS CHINENSIS; LAMIACEAE; MUS; POLYGONACEAE; RANUNCULACEAE; RATTUS; RHEUM OFFICINALE; SCUTELLARIA BAICALENSIS; SCUTELLARIA RADIX;

ALKALOIDS; ANGIOSPERMS; ANIMALS; ANTHRAQUINONES; ANTI-INFLAMMATORY AGENTS; COPTIS; CYTOKINES; DRUGS, CHINESE HERBAL; FLAVONES; FLAVONOIDS; INFLAMMATION; INTERLEUKIN-10; MICE; MICE, INBRED STRAINS; RATS; RATS, SPRAGUE-DAWLEY; RHEUM; SCUTELLARIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84889598759     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0033-1350959     Document Type: Article

References (36)

1. Chen R. C. Survey of Xiexin Tang categorized formulas. J Tradit Chin Med: 2008; 7 19 22
2. Ma B. L., Ma Y. M., Yan D. M., Zhou H., Shi R., Wang T. M., Yang Y., Wang C. H., Zhang N. Effective constituents in Xiexin decoction for anti-inflammation. J Ethnopharmacol: 2009; 125 151 156
3. Lo Y. C., Lin Y. L., Yu K. L., Lai Y. H., Wu Y. C., Ann L. M., Chen I. J. San-Huang-Xie-Xin-Tang attenuates inflammatory responses in lipopolysaccharide-exposed rat lungs. J Ethnopharmacol: 2005; 101 68 74 (Pubitemid 41265603)
4. Lo Y. C., Tsai P. L., Huang Y. B., Shen K. P., Tsai Y. H., Wu Y. C., Lai Y. H., Chen I. J. San-Huang-Xie-Xin-Tang reduces lipopolysaccharides-induced hypotension and inflammatory mediators. J Ethnopharmacol: 2005; 96 99 106
5. Lee J. C., Tseng C. K., Wu S. F., Chang F. R., Chiu C. C., Wu Y. C. San-Huang-Xie-Xin-Tang extract suppresses hepatitis C virus replication and virus-induced cyclooxygenase-2 expression. J Viral Hepat: 2011; 18 315 324
6. Liu B. L., Xuan Y. Y., Wang X. H., Liu X. H. Pharmacodynamic study of Sanhuang Xiexin Tan for treatment of upper gastrointestinal hemorrhage. Pharm Clin Chin Mater Med: 2003; 19 1 3
7. Saegusa Y., Sugiyama A., Takahara A., Nagasawa Y., Hashimoto K. Relationship between phosphodiesterase inhibition induced by several Kampo medicines and smooth muscle relaxation of gastrointestinal tract tissues of rats. J Pharmacol Sci: 2003; 93 62 68 (Pubitemid 37254268)
8. Shih Y. T., Wu D. C., Liu C. M., Yang Y. C., Chen I. J., Lo Y. C. San-Huang-Xie-Xin-Tang inhibits Helicobacter pylori -induced inflammation in human gastric epithelial AGS cells. J Ethnopharmacol: 2007; 112 537 544
9. Li T. K. Tentative study of solvent for decocting drug in treaties on cold damage diseases. Res Tradit Chin Med: 1997; 1 31 32
10. Zan B., Shi R., Wang T. M., Wu J. S., Ma Y. M., Cheng N. N. Simultaneous quantification of multiple active components from Xiexin decoction in rat plasma by LC-ESI-MS/MS: application in pharmacokinetics. Biomed Chromatogr: 2011; 25 816 826
11. Shia C. S., Hou Y. C., Juang S. H., Tsai S. Y., Hsieh P. H., Ho L. C., Chao P. D. Metabolism and pharmacokinetics of San-Huang-Xie-Xin-Tang, a polyphenol-rich Chinese medicine formula, in rats and ex-vivo antioxidant activity. Evid Based Complement Alternat Med: 2011; 2011 1 9
12. Yan D. M., Ma Y. M. Simultaneous quantification of five anthraquinones in rat plasma by high-performance liquid chromatography with fluorescence detection. Biomed Chromatogr: 2007; 21 502 507
13. Ma Y. M., Yan J. C., Wang T. M., Shi R., Jiao Y. B. Anti-inflammatory effects of Xiexin decoction on animal models of acute inflammation. Chin Pharmacol Bull: 2006; 22 1393 1398
14. Zhang Q., Wang C. H., Ma Y. M., Zhu E. Y., Wang Z. T. UPLC-ESI/MS determination of 17 active constituents in two categorized formulas of traditional Chinese medicine, Sanhuang Xiexin Tang and Fuzi Xiexin Tang: application in comparing with the difference in decoctions and macerations. Biomed Chromatogr: 2013; 27 1079 1088
15. Sheng M. P., Sun Q., Wang H. Studies on the intravenous pharmacokinetics and oral absorption of berberine HCI in beagle dogs. Chin Pharmacol Bull: 1993; 9 64 67 (Pubitemid 23160416)
16. Zeng X. Relationship between the clinical effects of berberine on severe congestive heart failure and its concentration in plasma studied by HPLC. Biomed Chromatogr: 1999; 13 442 444 (Pubitemid 29533134)
17. Yu S., Pang X. Y., Deng Y. X., Liu L., Liang Y., Liu X. D., Xie L., Wang G. J., Wang X. T. A sensitive and specific liquid chromatography mass spectrometry method for simultaneous determination of berberine, palmatine, coptisine, epiberberine and jatrorrhizine from Coptidis Rhizoma in rat plasma. Int J Mass Spectrom: 2007; 268 30 37
18. Tsaia P. L., Tsai T. H. Simultaneous determination of berberine in rat blood, liver and bile using microdialysis coupled to high-performance liquid chromatography. J Chromatogr A: 2002; 961 125 130
19. Ozaki Y., Suzuki H., Satake M. Comparative studies on concentration of berberine in plasma after oral administration of coptidis rhizoma extract, its cultured cells extract, and combined use of these extracts and glycyrrhizae radix extract in rats. Yakugaku Zasshi: 1993; 113 63 69 (Pubitemid 23106455)
20. Liu F. Q., Li Z. D., Shi X. J., Zhong M. K. Determination of berberine, palmatine and jatrorrhizine in rabbit plasma by liquid chromatography- electrospray ionization-mass spectrometry. J Pharm Biomed Anal: 2011; 56 1006 1015
21. Lu T., Liang Y., Song J., Xie L., Wang G. J., Liu X. D. Simultaneous determination of berberine and palmatine in rat plasma by HPLC-ESI-MS after oral administration of traditional Chinese medicinal preparation Huang-Lian-Jie-Du decoction and the pharmacokinetic application of the method. J Pharm Biomed Anal: 2006; 40 1218 1224 (Pubitemid 43247461)
22. Yu S., Yu Y. L., Liu L., Wang X. T., Lu S. S., Liang Y., Liu X. D., Xie L., Wang G. J. Increased plasma exposures of five protoberberine alkaloids from Coptidis Rhizoma in streptozotocin-induced diabetic rats: is P-gP involved? Planta Med: 2010; 76 876 881
23. Liu Y. T., Hao H. P., Xie H. G., Lai L., Wang Q., Liu C. X., Wang G. J. Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats. Drug Metab Dispos: 2010; 38 1779 1784
24. Qiu W., Jiang X. H., Liu C. X., Ju Y., Jin J. X. Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp. Phytother Res: 2009; 23 1553 1558
25. Li Y., Ren G., Wang Y. X., Kong W. J., Yang P., Wang Y. M., Li Y. H., Yi H., Li Z. R., Song D. Q., Jiang J. D. Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes. J Transl Med: 2011; 9 62 71
26. Wang L., Ye X. L., Li X. G., Chen Z., Chen X. D., Gao Y., Zhao Z. Q., Huang W. W., Yi J. Metabolism, transformation and distribution of Coptidis Rhizoma total alkaloids in rat. China J Chin Mater Med: 2010; 35 2017 2020
27. Xing J., Chen X. Y., Zhong D. F. Absorption and enterohepatic circulation of baicalin in rats. Life Sci: 2005; 78 140 146 (Pubitemid 41560966)
28. Plusquellec Y., Efthymiopoulos C., Duthil P., Houin G. A pharmacokinetic model for multiple sites discontinuous gastrointestinal absorption. Med Eng Phys: 1999; 21 525 532
29. Tu X. K., Yang W. Z., Shi S. S., Chen Y., Wang C. H., Chen C. M., Chen Z. Baicalin inhibits TLR2/4 signaling pathway in rat brain following permanent cerebral ischemia. Inflammation: 2010; 34 463 470
30. Cong X. D., Ding M. J., Dai D. Z., Wu Y., Zhang Y., Dai Y. ER stress, P66shc, and P-Akt/Akt mediate adjuvant-induced inflammation, which is blunted by argirein, a supermolecule and rhein in rats. Inflammation: 2011; 35 1031 1040
31. Lim H. A., Lee E. K., Kim J. M., Park M. H., Kim D. H., Choi Y. J., Ha Y. M., Yoon J. H., Choi J. S., Yu B. P., Chung H. Y. PPAR γ activation by baicalin suppresses NF- κ B-mediated inflammation in aged rat kidney. Biogerontology: 2011; 13 133 145
32. Martin G., Bogdanowicz P., Domagala F., Ficheux H., Pujol J. P. Rhein inhibits interleukin-1 β -induced activation of MEK/ERK pathway and DNA binding of NF- κ B and AP-1 in chondrocytes cultured in hypoxia: a potential mechanism for its disease-modifying effect in osteoarthritis. Inflammation: 2003; 27 233 246 (Pubitemid 37034471)
33. Piao H. Z., Jin S. A., Chun H. S., Lee J. C., Kim W. K. Neuroprotective effect of wogonin potential roles of inflammatory cytokines. Arch Pharm Res: 2004; 27 930 936
34. Li Y., Xu X. The content condition of effective composition in Sanhuang Xiexin decoction. China J Chin Mater Med: 2006; 31 383 385
35. Li C. Y., Hou Y. C., Chao P. D., Shia C. S., Hsu I. C., Fang S. H. Potential ex vivo immunomodulatory effects of San-Huang-Xie-Xin-Tang and its component herbs on mice and humans. J Ethnopharmacol: 2010; 127 292 298
36. Ma B. L., Ma Y. M., Yan D. M., Zhou H., Shi R., Wang T. M., Yang Y., Wang C. H., Zhang N. Effective constituents in Xiexin decoction for anti-inflammation. J Ethnopharmacol: 2009; 125 151 156